AETHLON MEDICAL INC Stock Prediction
AI-powered sentiment analysis and prediction trends for AEMD, updated each market day.
AEMD AI Sentiment
AI sees no strong directional signal for AETHLON MEDICAL INC stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About AETHLON MEDICAL INC
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
Sector
Exchange
Market Cap
$4,821,502
Cap Tier
Employees
9
Headquarters
SAN DIEGO, CA
Listed Since
Nov. 6, 1998
Website
AEMD Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
AEMD Volatility
AETHLON MEDICAL INC has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
